The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 18, 2020

Filed:

May. 13, 2016
Applicant:

Seoul National University R&db Foundation, Seoul, KR;

Inventors:

Hyo-Soo Kim, Seoul, KR;

Jung-Kyu Han, Anyang-si, KR;

Sung-Hwan Chang, Seoul, KR;

Hyun-Ju Cho, Seoul, KR;

Saet-Byeol Choi, Gyeongsangbuk-do, KR;

Youngchul Shin, Seoul, KR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/44 (2015.01); C12N 5/071 (2010.01); C12N 5/16 (2006.01); C12N 5/077 (2010.01);
U.S. Cl.
CPC ...
A61K 35/44 (2013.01); C12N 5/069 (2013.01); C12N 5/0656 (2013.01); C12N 5/16 (2013.01); C12N 2501/60 (2013.01); C12N 2506/1307 (2013.01); C12N 2510/00 (2013.01);
Abstract

The present invention relates to a method of preparing vascular endothelial cells by transforming (transdifferentiating) adult fibroblasts and a composition, which includes vascular endothelial cells prepared according to the method, for preventing and treating ischemic diseases, the method including a step of transducing adult fibroblasts with a gene. In particular, the present invention confirms that five factors, Foxo1, Er71, Klf2, Tal1, and Lmo2, induce transdifferentiation of adult fibroblasts into induced vascular endothelial cells. Furthermore, the present invention confirms that three factors, Er71, Klf2, and Tal1 induce transdifferentiation of human adult fibroblasts into induced vascular endothelial cells. The resultant induced endothelial cells enable lower limb salvaging by angiogenesis in lower limb ischemic animal models, showing that the induced endothelial cells can be effectively used for prevention or treatment of ischemic diseases.


Find Patent Forward Citations

Loading…